KNAUF, Sascha, Simone LUERT, David ŠMAJS, Michal STROUHAL, Idrissa S. CHUMA, Sieghard FRISCHMANN and Mohammed BAKHEIT. Gene target selection for loop-mediated isothermal amplification for rapid discrimination of Treponema pallidum subspecies. PLoS neglected tropical diseases. San Francisco: Public Library of Science, 2018, vol. 12, No 4, p. 1-14. ISSN 1935-2735. Available from: https://dx.doi.org/10.1371/journal.pntd.0006396.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Gene target selection for loop-mediated isothermal amplification for rapid discrimination of Treponema pallidum subspecies
Authors KNAUF, Sascha (276 Germany, guarantor), Simone LUERT (276 Germany), David ŠMAJS (203 Czech Republic, belonging to the institution), Michal STROUHAL (203 Czech Republic, belonging to the institution), Idrissa S. CHUMA (276 Germany), Sieghard FRISCHMANN (276 Germany) and Mohammed BAKHEIT (276 Germany).
Edition PLoS neglected tropical diseases, San Francisco, Public Library of Science, 2018, 1935-2735.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30309 Tropical medicine
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 4.487
RIV identification code RIV/00216224:14110/18:00104105
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1371/journal.pntd.0006396
UT WoS 000433487700036
Keywords in English gene target
Tags 14110513, rivok
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 10/2/2019 13:08.
Abstract
We show proof of concept for gene targets (polA, tprL, and TP_0619) that can be used in loop-mediated isothermal amplification (LAMP) assays to rapidly differentiate infection with any of the three Treponema pallidum subspecies (pallidum (TPA), pertenue (TPE), and endemicum (TEN)) and which are known to infect humans and nonhuman primates (NHPs). Four TPA, six human, and two NHP TPE strains, as well as two human TEN strains were used to establish and validate the LAMP assays. All three LAMP assays were highly specific for the target DNA. Amplification was rapid (5-15 min) and within a range of 10E+6 to 10E+2 of target DNA molecules. Performance in NHP clinical samples was similar to the one seen in human TPE strains. The newly designed LAMP assays provide proof of concept for a diagnostic tool that enhances yaws clinical diagnosis. It is highly specific for the target DNA and does not require expensive laboratory equipment. Test results can potentially be interpreted with the naked eye, which makes it suitable for the use in remote clinical settings.
PrintDisplayed: 17/7/2024 16:37